Celularity Q4 EPS $(0.03)
Celularity (NASDAQ:CELU) reported quarterly losses of $(0.03) per share.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Celularity Received FDA Orphan Drug Designation for its Treatment for Gastric/Gastroesophageal Junction Cancer
Link: https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=862521
Oppenheimer Initiates Coverage On Celularity with Outperform Rating, Announces Price Target of $9
Oppenheimer analyst Matthew Biegler initiates coverage on Celularity (NASDAQ:CELU) with a Outperform rating and announces Price Target of $9.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.